News & Analysis on Clinical Trial Services & Contract Research And Development
A study that has uncovered core functional differences between a new oestrogen receptor could form the basis of novel and potentially more effective treatments of breast cancer as researchers sought to utilise this therapeutic target.
PerkinElmer has launched a new antibody-free kinase assay technology that is set to play a major role in drug discovery by allowing researchers to perform direct measurements of kinase activities on full-length protein substrates where no antibody is...
A membrane protein factory, which represents over half of all known drug targets could lead to new and improved pharmaceutical treatments for a broad range of illnesses such as depression, heart disease, addictions and cystic fibrosis.
Drug delivery firm Egalet has asked SP Medical, a manufacturer of moulded plastics and coatings, to make sufficient clinical grade quantities of its therapeutics using injection moulding, which allows for greater uniformity and reproducibility in the...
Velocity11 has made available globally, a gripper accessory for its Bravo Liquid Handling Platform that enables a broader range of fully automated applications to be achieved by the compact Bravo platform.
Invitrogen has announced the opening of a new research facility to be located in Scotland. The decision adds to the investment influx within the region, which has seen 20 per cent of the UK's biotech companies set up research capacities there.
Nastech has secured a contract with Procter & Gamble (P&G) to ramp up manufacturing capacity for a new needle-free drug to beat osteoporosis, in anticipation of meeting expected global demand once the product is approved.
Pall is organising a free chromatography seminar in Paris this week presented by leading chromatographers from the pharmaceutical, biotechnology and biologicals industries.
Biotechnology firm Invitrogen has opened a new facility in New York which can make its Advanced Granulation Technology (AGT) media totally free of animal origin components while addressing key bottlenecks in drug production.